Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2002
10/31/2002US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002US20020161005 Nitrogen heterocycle compounds
10/31/2002US20020161004 Antiinflammation agents
10/31/2002US20020161000 Treating diseases resulting from tissue breakdown such as heart disease, multiple sclerosis, osteo- and rheumatoid arthritis, atherosclerosis, and osteoporosis
10/31/2002US20020160988 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
10/31/2002US20020160968 Inhibitor of niacinamide phosphoribosyl transferase (NAPRT)
10/31/2002US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002US20020158255 Compounds of the general formula P1-L-P2; wherein "P1" is a pyrazinoylguanidine sodium channel blocker, "L" is a linking group, and "P2" is either (i) a pyrazinoylguanidine sodium channel blocker or (ii) a P2Y2 receptor agonist, are disclosed
10/31/2002CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002CA2445236A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002CA2444599A1 Melanocortin receptor ligands
10/31/2002CA2444595A1 Benzimidazolone derivatives
10/31/2002CA2444592A1 Novel azoles having an insecticidal action
10/31/2002CA2444381A1 Novel compounds
10/31/2002CA2444095A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002CA2444036A1 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002CA2443605A1 Process for purifying 6-methoxy omeprazole
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/30/2002EP1252162A1 Alpha v integrin receptor antagonists
10/30/2002EP1252159A1 Method for producing heterocyclic compounds
10/30/2002EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002EP1252156A1 Blockade of voltage dependent sodium channels
10/30/2002EP1252154A1 Heterocyclic amide derivatives
10/30/2002EP1252153A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
10/30/2002EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002EP1252145A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/30/2002EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002EP1252140A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/30/2002EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251854A2 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
10/30/2002EP1251851A1 Treating allergic and inflammatory conditions
10/30/2002EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
10/30/2002EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002EP0852225B1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
10/30/2002EP0799221B1 Quinazolines as inhibitors of endothelin converting enzyme
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377345A Herbicidally active pyridine sulfonyl urea derivatives
10/30/2002CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1376677A [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application
10/30/2002CN1093540C Method for extracting nicotine and melim from low quality tobacco leaves
10/30/2002CN1093535C Imiazole derivative
10/30/2002CN1093534C Cationic polypeptide condensting agent of pyridine, its synthesis and application
10/29/2002US6472536 Such as 2-(4-(4-cyclopentyloxybenzyl)phenyl)amino-imidazoline; antinociceptive agents; ip receptor antagonists; treating inflammatory pain
10/29/2002US6472529 Viricides
10/29/2002US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002US6472456 Polyolefins, especially polypropylene, can be made flame retardant by the incorporation therein of a synergistic mixture of a selected hindered amine substituted by an alkoxy, cydoalkoxy or hydroxyalkoxy moiety and a selected
10/29/2002US6472418 Non-peptide NK1 receptors antagonists
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472410 N-cyclopentyl modulators of chemokine receptor activity
10/29/2002US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002US6472404 HIV protease inhibitors
10/29/2002US6472403 αV integrin receptor antagonists
10/29/2002US6472399 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/29/2002US6472397 Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof
10/29/2002US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002US6472394 MCH antagonists and their use in the treatment of obesity
10/29/2002US6472392 Triazole compounds and the use thereof as dopamine-D3 -ligands
10/29/2002US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/29/2002US6472348 Pyridone derivatives and herbicides
10/29/2002CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/28/2002WO2001082909A2 2-acyl indol derivatives and their use as anti-tumour agents
10/28/2002CA2407677A1 2-acyl indol derivatives and their use as anti-tumour agents
10/24/2002WO2002083781A1 Long chain hindered amines and compositions stabilized therewith
10/24/2002WO2002083665A1 DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
10/24/2002WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083662A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
10/24/2002WO2002083656A2 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
10/24/2002WO2002083654A1 Triazinyl amide derivatives as angiogenesis inhibitors
10/24/2002WO2002083653A1 Triazinyl acrylamide derivatives as kinase inhibitors
10/24/2002WO2002083652A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
10/24/2002WO2002083650A1 Novel sulfonylamino-pyrimidines
10/24/2002WO2002083645A1 Novel compounds
10/24/2002WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002WO2002083641A2 Amino-aza-cyclohexanes for the treatment of malaria
10/24/2002WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002WO2002083608A2 Methods of preparing sulfinamide and sulfoxides
10/24/2002WO2002083145A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002WO2002083143A1 Cxcr3 antagonists
10/24/2002WO2002083134A1 Aryl and biaryl piperidines used as mch antagonists
10/24/2002WO2002083125A1 Method of inhibiting adhesion formation
10/24/2002WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002WO2002083109A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002WO2002074763A9 Benzimidazol derivatives modulate chemokine receptors
10/24/2002WO2002057253A3 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002WO2002050057A8 Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
10/24/2002WO2002030897A3 Compositions and methods for regulating the nervous system
10/24/2002WO2002024659A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists
10/24/2002WO2002000650A3 Novel compounds possessing antibacterial, antifungal or antitumor activity
1 ... 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 ... 1080